Novel sunitinib strategy in metastatic renal cell carcinoma on hemodialysis: intermittent dose of sunitinib after hemodialysis
about
Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials.Intolerance to sunitinib treatment in hemodialysis patients with metastatic renal cell carcinomaRecent aspects of sunitinib therapy in patients with metastatic clear-cell renal cell carcinoma: a systematic review of the literature.Feasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experience.
P2860
Novel sunitinib strategy in metastatic renal cell carcinoma on hemodialysis: intermittent dose of sunitinib after hemodialysis
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Novel sunitinib strategy in me ...... f sunitinib after hemodialysis
@ast
Novel sunitinib strategy in me ...... f sunitinib after hemodialysis
@en
Novel sunitinib strategy in me ...... f sunitinib after hemodialysis
@nl
type
label
Novel sunitinib strategy in me ...... f sunitinib after hemodialysis
@ast
Novel sunitinib strategy in me ...... f sunitinib after hemodialysis
@en
Novel sunitinib strategy in me ...... f sunitinib after hemodialysis
@nl
prefLabel
Novel sunitinib strategy in me ...... f sunitinib after hemodialysis
@ast
Novel sunitinib strategy in me ...... f sunitinib after hemodialysis
@en
Novel sunitinib strategy in me ...... f sunitinib after hemodialysis
@nl
P2093
P2860
P1476
Novel sunitinib strategy in me ...... f sunitinib after hemodialysis
@en
P2093
Gun Min Kim
Hyo Song Kim
Joo Hoon Kim
Junjeong Choi
Ki Hyang Kim
Sang Hyun Yoon
P2860
P304
P356
10.4143/CRT.2010.42.3.180
P577
2010-09-30T00:00:00Z